Genesis IBRC India [GENESIS] vs Dishman Carbogen [DCAL] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Genesis IBRC India Ltd. wins in 3 metrics, Dishman Carbogen Amcis Ltd. wins in 11 metrics, with 1 ties. Dishman Carbogen Amcis Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Genesis IBRC India Ltd. | Dishman Carbogen Amcis Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 57.89 | 22.30 | Dishman Carbogen Amcis Ltd. |
| Price-to-Book Ratio | 9.93 | 0.42 | Dishman Carbogen Amcis Ltd. |
| Debt-to-Equity Ratio | 0.00 | 40.20 | Tie |
| PEG Ratio | N/A | -0.16 | N/A |
| EV/EBITDA | 26.95 | 9.62 | Dishman Carbogen Amcis Ltd. |
| Profit Margin (TTM) | 2.36% | 4.25% | Dishman Carbogen Amcis Ltd. |
| Operating Margin (TTM) | -11.05% | 3.99% | Dishman Carbogen Amcis Ltd. |
| EBITDA Margin (TTM) | N/A | 3.99% | N/A |
| Return on Equity | 0.08% | 0.06% | Genesis IBRC India Ltd. |
| Return on Assets (TTM) | 0.05% | 0.03% | Genesis IBRC India Ltd. |
| Free Cash Flow (TTM) | $-3,000 | $1.58B | Dishman Carbogen Amcis Ltd. |
| 1-Year Return | 365.12% | -33.95% | Genesis IBRC India Ltd. |
| Price-to-Sales Ratio (TTM) | 1,399.83 | 0.95 | Dishman Carbogen Amcis Ltd. |
| Enterprise Value | $944.70M | $46.55B | Dishman Carbogen Amcis Ltd. |
| EV/Revenue Ratio | 326.10 | 1.66 | Dishman Carbogen Amcis Ltd. |
| Gross Profit Margin (TTM) | N/A | 80.34% | N/A |
| Revenue per Share (TTM) | $0 | $179 | Dishman Carbogen Amcis Ltd. |
| Earnings per Share (Diluted) | $-0.18 | $7.58 | Dishman Carbogen Amcis Ltd. |
| Beta (Stock Volatility) | N/A | 0.40 | N/A |
Genesis IBRC India Ltd. vs Dishman Carbogen Amcis Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Genesis IBRC India Ltd. | 4.73% | -1.84% | -15.78% | -0.56% | 14.28% | 15.99% |
| Dishman Carbogen Amcis Ltd. | -2.38% | -2.24% | -7.21% | 9.02% | -19.76% | -29.73% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Genesis IBRC India Ltd. | 365.12% | 779.33% | 1,160.05% | 482.04% | 4,600.00% | 4,600.00% |
| Dishman Carbogen Amcis Ltd. | -33.95% | 46.77% | -6.77% | 33.46% | 290.77% | 118.12% |
Performance & Financial Health Analysis: Genesis IBRC India Ltd. vs Dishman Carbogen Amcis Ltd.
| Metric | GENESIS | DCAL |
|---|---|---|
| Market Information | ||
| Market Cap | ₹4.47B | ₹26.50B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 250 | 337,264 |
| 90 Day Avg. Volume | 317 | 517,904 |
| Last Close | ₹98.45 | ₹180.24 |
| 52 Week Range | ₹20.21 - ₹181.30 | ₹128.50 - ₹321.95 |
| % from 52W High | -45.70% | -44.02% |
| All-Time High | ₹184.90 (Nov 11, 2025) | ₹396.40 (Jan 22, 2018) |
| % from All-Time High | -46.76% | -54.53% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | 0.06% |
| Quarterly Earnings Growth | N/A | -0.09% |
| Financial Health | ||
| Profit Margin (TTM) | 0.02% | 0.04% |
| Operating Margin (TTM) | -0.11% | 0.04% |
| Return on Equity (TTM) | 0.00% | 0.00% |
| Debt to Equity (MRQ) | 0.00 | 40.20 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹9.02 | ₹405.67 |
| Cash per Share (MRQ) | ₹5.26 | ₹40.41 |
| Operating Cash Flow (TTM) | ₹0 | ₹-199,700,000 |
| Levered Free Cash Flow (TTM) | ₹35.05M | ₹32.40M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Genesis IBRC India Ltd. vs Dishman Carbogen Amcis Ltd.
| Metric | GENESIS (Apr 24, 2026) | DCAL (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 57.89 | 22.30 |
| Forward P/E | N/A | 13.52 |
| PEG Ratio | N/A | -0.16 |
| Price to Sales (TTM) | 1,399.83 | 0.95 |
| Price to Book (MRQ) | 9.93 | 0.42 |
| Market Capitalization | ||
| Market Capitalization | ₹4.47B | ₹26.50B |
| Enterprise Value | ₹944.70M | ₹46.55B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 326.10 | 1.66 |
| Enterprise to EBITDA | 26.95 | 9.62 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.40 |
| Book Value per Share (MRQ) | ₹9.02 | ₹405.67 |
Financial Statements Comparison: Genesis IBRC India Ltd. vs Dishman Carbogen Amcis Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | GENESIS (2025) | DCAL (2025) |
|---|---|---|
| Revenue/Sales | 0 | 26.42B |
| Cost of Goods Sold | 0 | 5.26B |
| COGS % of Revenue | - | 19.9% |
| Gross Profit | 0 | 21.16B |
| Gross Margin | - | 80.1% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 35.05M | 1.46B |
| Operating Margin | - | 5.5% |
| EBITDA | 35.05M | 4.83B |
| EBITDA Margin | - | 18.3% |
| Pre-Tax Income | 35.05M | 193.10M |
| Pre-Tax Income % of Revenue | - | 0.7% |
| Income Tax | 0 | 160.70M |
| Income Tax % of Revenue | - | 0.6% |
| Net Income (Profit) | 35.05M | 32.40M |
| Profit Margin | - | 0.1% |
Balance Sheet & Liquidity Metrics
| Metric | GENESIS (2025) | DCAL (2025) |
|---|---|---|
| Cash & Equivalents | 57,000 | 2.86B |
| Total Current Assets | 88.35M | 22.00B |
| Total Current Assets % of Revenue | - | 83.3% |
| Total Current Liabilities | 3.03M | 19.25B |
| Total Current Liabilities % of Revenue | - | 72.9% |
| Long-Term Debt | N/A | 13.90B |
| Long-Term Debt % of Revenue | - | 52.6% |
| Total Shareholders Equity | 85.33M | 58.32B |
| Retained Earnings | -83.06M | 2.13B |
| Retained Earnings % of Revenue | - | 8.1% |
| Property, Plant & Equipment | N/A | 10.27B |
Cash Flow Statement Comparison
| Metric | GENESIS (2025) | DCAL (2025) |
|---|---|---|
| Operating Cash Flow | 0 | -199.70M |
| Operating Cash Flow % of Revenue | - | -0.8% |
| Capital Expenditures | N/A | -2.15B |
| Free Cash Flow | -3,000 | 1.58B |
| FCF Margin | - | 6.0% |
| Debt Repayment | N/A | -1.10B |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | GENESIS | DCAL |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 45.25M | 156.78M |
| Float Shares | N/A | 54.95M |
| % Held by Insiders | 27.24% | 69.30% |
| % Held by Institutions | 0.00% | 2.41% |
| % Held by Public | 72.76% | 28.29% |
Dividend Analysis & Yield Comparison: Genesis IBRC India Ltd. vs Dishman Carbogen Amcis Ltd.
| Metric | GENESIS | DCAL |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | ₹0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | ₹0.00 |
| Ex-Dividend Date | N/A | N/A |